Smith+Nephew Finally Taps Into Market Upside

Smith+Nephew reported 3Q23 orthopedic sales of $902 million, +8.4% compared to the third quarter of 2022. For the first nine months of the year, the company generated $2,755.3 million in orthopedic sales, +5.5% year-over-year.

The third quarter marked the company's best orthopedic performance in years, according to its leadership....

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0